We are committed to developing important new medicines to treat life-altering central nervous system (CNS) disorders.
"Studies have shown that approximately one third of epilepsy patients have epilepsy that fails to respond to treatment. Many of these patients have what is called orphan genetic epilepsies which tend to be severe and begin in early childhood. The Foundation wants the door to be open for research because our population who fail to respond to current treatments need new options. Our vision is a world without epilepsy and seizures.”
- Susan Welby, Director of Programs, Epilepsy Foundation of Mass, RI, NH & ME.
We seek to shift perceptions about CNS disorders and develop medicines that may bring hope to patients who are in need of new or additional treatment options. We’re originating meaningfully differentiated drug candidates, with one important goal: to make life better for patients and their families.
When it comes to facing life-altering CNS disorders, you’re not alone. We encourage you to visit the websites of the following advocacy organizations, which are also pursuing better treatments for patients living with CNS disorders.